Introducing next-generation sequencing into the clinical care of cancer - European Medical Journal

Continue

Introducing next-generation sequencing into the clinical care of cancer

Oncology

At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm, Sweden, discusses the value of the clinical use of next-generation sequencing for cancer management, including the accelerating trend towards evidence-based, multigene-driven personalised cancer therapeutics.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given